Nexalin Technology, Inc. — Investor Relations & Filings

Nexalin Technology, Inc. is a medical technology company that develops non-invasive neurostimulation devices for mental and neurological health conditions. Its core technology utilizes a patented, frequency-based waveform designed to interact with deep brain structures to modulate neurochemicals, offering a drug-free treatment alternative. The company's devices are FDA-cleared for the treatment of anxiety, insomnia, and depression. Nexalin is advancing its technology through clinical trials for expanded applications, including treatment-resistant depression, Alzheimer's disease, and substance use disorders. It is also developing next-generation systems, such as the Gen-2 and HALO devices, with a focus on enhanced therapeutic benefits and potential at-home use.